Rational Fluid Therapy in Germany

Patients in ICU Clinical Trial

— RaFTinG  

Official title:

Klinisches Register RaFTinG - Rational Fluid Therapy in Germany

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT01122277
• Other study ID #: 337 -09/2009-366-f-S
• Status: Active, not recruiting
• Phase: N/A
• First received: May 11, 2010
• Last updated: July 7, 2011
• Start date: May 2010
• Est. completion date: October 2011

Study information

• Verified date: October 2010
• Source: Ludwig-Maximilians - University of Munich
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Federal Institute for Drugs and Medical Devices
• Study type: Observational

Clinical Trial Summary

The purpose of this observational study is the prospective documentation and evaluation of the status quo of volume therapy in German intensive care units.

Description:

The purpose of RaFTinG is the prospective documentation and evaluation of the demographic, diagnostic and therapeutic characteristics of unselected patients and their treatment in intensive care units (ICU) in Germany.

Documentation will not only include their stay in the ICU but a follow up query 90 days after discharge from the ICU.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 4000
• Est. completion date: October 2011
• Est. primary completion date: May 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• ICU patients with an indication for fluid/volume therapy

Exclusion Criteria:

• Patients hospitalized by order of a court of law or a government agency

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Patients in ICU

Locations

Country	Name	City	State
Germany	Klinik für Anaesthesiologie, Klinikum der Universität München	Munich	Bavaria
Germany	Universitätsklinikum Münster	Münster	Nordrhein - Westfalen

Sponsors (3)

Lead Sponsor	Collaborator
Ludwig-Maximilians - University of Munich	Fresenius Kabi, Bad Homburg, Germany, University Hospital Muenster

Country where clinical trial is conducted

Germany,